Portolano Cavallo Life Sciences Blog

20 Jun 23

European Commission proposals for new regulation of compulsory licensing

On April 27, 2023, the European Commission published proposals for a new set of regulations aimed at establishing a more transparent and effective framework for patent rights.

European Commission, Regulation, Patents

19 Jun 23

Processing health data on online platforms: The Garante rules on fairness

With order no. 368 of November 10, 2022, the Italian Data Protection Authority ruled that the provider of an online platform aimed at connecting healthcare professionals with patients was in breach of the personal data protection rules provided by the GDPR in processing data via their platform.

Data Protection, Health Data, Privacy & Cyber Security

19 Jun 23

Non-promotional communication: Boost for digital from the Farmindustria Code?

The recent amendments to the Farmindustria Code on non-promotional drug interactions may boost pharmaceutical companies’ communication via digital and other channels.

Digital Health, Advertising, Promotion

14 Jun 23

Drug advertising: New directions from Europe

Europe is not making any revolutionary changes when it comes to the advertising of medicines.

Advertising, Promotion, Generic Drugs, Pharma, Prescription Drugs, Veterinary Drugs

Welcome to the Portolano Cavallo Life Sciences blog focusing on legal development and key legal issues affecting the life sciences and healthcare industry.

...

Our highly-ranked team of professionals will provide news, insights and multidisciplinary commentary on the hottest and most recent regulatory, transactional and contentious aspects of the pharmaceutical, bio-tech, med-tech, food supplement and healthcare world with an eye on its digital transformation and technological developments.

This blog will be a place for focusing on digital health, telemedicine and artificial intelligence, as well as more traditional topics: from the protection of intellectual properties to performance of clinical trials, from the market access to advertising and competition issues, from internal and criminal investigations to M&A and venture capital transactions.

Flash News

October 6, 2023

CBD products: the Administrative Court suspended until October 24 the recent Decree of the Italian Ministry of Health listing cannabidiol for oral use among narcotic drugs, due to the lack o...

October 4, 2023

The Guidelines for regulating contractual relations between universities and research institutes and private sponsors were adopted by the relevant Italian Ministries following the amendment ...

September 21, 2023

CBS products: from September 20th, compositions for oral administration of cannabidiol obtained from Cannabis sativa extracts shall be considered as narcotic drugs in Italy, as they have bee...

July 27, 2023

Payback on medical devices: Italian government announces extension of payment deadline to October 30, 2023

July 21, 2023

On July 21, 2023, the Italian Ministry of Health published new guidelines on health advertising of self-medication drugs (OTC) and non-prescription drugs (SOP), including advertising on new ...

Search by...